News
Academy
Publications
Media
Conferences
Columns
Resources
Webcasts
Subscribe

Technology

Latest News

May 17th 2024

Putting LP-284 on the Industry RADR

By Miranda Schmalfuhs

Panna Sharma, CEO of Lantern Pharma, discusses LP-284, using their RADR during testing, ensuring global use, and what the future holds.

Conference Calls for Unity in Addressing Artificial Intelligence Regulation in Life Sciences Research and Development

By Don Tracy, Associate Editor

Image credit: NicoElNino | stock.adobe.com

April 29th 2024

AI in Clinical Trials: The Future of Drug Discovery

By Nancy Kapila

Latest Videos

Reliance on Traditional Research Methods

Reliance on Traditional Research Methods

Implementing Virtual Models in Clinical Trials: Results from PicnicHealth’s Annual State of Observational Research Report

Implementing Virtual Models in Clinical Trials: Results from PicnicHealth’s Annual State of Observational Research Report

Enhancing Patient Engagement and Data Accuracy in Decentralized Trials

Enhancing Patient Engagement and Data Accuracy in Decentralized Trials

Determining the Effectiveness of Decentralization Across Different Trials

Determining the Effectiveness of Decentralization Across Different Trials

The Role of Quality Data in Utilizing Machine Learning Models

The Role of Quality Data in Utilizing Machine Learning Models

Implementing Technology into Clinical Operations Workflows

Implementing Technology into Clinical Operations Workflows

Modernizing Patient Recruitment

Modernizing Patient Recruitment

Streamlining Patient Recruitment with Technology

Streamlining Patient Recruitment with Technology

Ensuring the Long-Term Effectiveness of Clinical Trials

Ensuring the Long-Term Effectiveness of Clinical Trials

Opportunities Amidst Recent Research Policy Challenges

Opportunities Amidst Recent Research Policy Challenges

More News

Trending on Applied Clinical Trials Online

Drug Repurposing Through AI-Driven In-Silico Clinical Trials

Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework

ACT Brief: CNS Trial Expansion, Vaccine Policy Debate, and New Leadership at FDA

CNS and Autoimmune Trials: Growth and Operational Implications

ACT Brief: Targeted Trial Growth, Site Startup Strains, and Leadership Shake-Up at FDA

© 2025 MJH Life Sciences^®

All rights reserved.